CJC-1295 + Ipamorelin 5mg/5mg (Without DAC)

CJC-1295 + Ipamorelin 5mg/5mg (No DAC) – Research Grade
Dual-peptide synergy designed for advanced growth hormone research.
This combination pairs CJC-1295 (No DAC), a growth hormone releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue. Together, they are widely studied for their ability to stimulate natural growth hormone release in a controlled and pulsatile manner.
Key Research Focus Areas
Growth hormone pulse stimulation
Recovery and tissue repair processes
Sleep cycle and recovery optimization
Body composition and metabolic research
Lean mass support and regeneration pathways
Why This Combination
Synergistic GH release: GHRH + GHRP pathway activation
Controlled release profile (No DAC): Shorter acting, more precise timing
Selective action: Ipamorelin minimizes unwanted side pathways
Why Choose Onyx Biotech
Verified purity with batch-specific COAs
Premium lyophilized dual-peptide blend
Precision-formulated 5mg / 5mg vials
Sterile, sealed, and quality controlled
Fast dispatch + express shipping Australia-wide 🇦🇺
Product Details
Compounds: CJC-1295 (No DAC) + Ipamorelin
Quantity: 5mg / 5mg per vial
Form: Lyophilized powder
Grade: Research use only
Important Notice
This product is intended for research purposes only. Not for human consumption.